ODEFSEY (emtricitabine/rilpivirine) Patient Assistance Program
Don’t let the high cost of brand single-tablet HIV regimens disrupt your treatment. We help eligible patients access Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide, FTC/RPV/TAF) is a once-daily, single-tablet HIV-1 regimen FDA-approved as a complete regimen for treatment-naïve adults and pediatric patients (≥35 kg) with HIV-1 RNA ≤100,000 copies/mL, and for virologically suppressed adults switching from another regimen.
- Without assistance, Odefsey costs commonly run approximately $3,200–$3,700 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Odefsey for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic Odefsey in the U.S. as of 2026 (rilpivirine and TAF are still patent-protected). HIV guidelines now generally prefer integrase-inhibitor-based regimens (Biktarvy, dolutegravir-based) for new starts; rilpivirine is reserved for select patients with low viral loads at initiation.
What Is Odefsey Prescription Assistance Program?
The Odefsey Prescription Assistance Program is a manufacturer-sponsored initiative that provides Odefsey at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV treatment patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, Odefsey costs roughly $3,200–$3,700/month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$3,600.00 | Save ~$3,530/mo |
| CVS Pharmacy | ~$3,700.00 | Save ~$3,630/mo |
| Walmart | ~$3,300.00 | Save ~$3,230/mo |
| Costco | ~$3,250.00 | Save ~$3,180/mo |
| Kroger | ~$3,300.00 | Save ~$3,230/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Odefsey Prescription Program?
The Patient Assistance Program is free to apply for and provides Odefsey at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Odefsey:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $3,200–$3,700 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Odefsey assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Odefsey Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Odefsey:
Odefsey (FTC/RPV/TAF) is a once-daily, single-tablet, three-drug HIV-1 regimen combining the NNRTI rilpivirine with the NRTI backbone of emtricitabine and tenofovir alafenamide.
How Odefsey Works:
Odefsey combats HIV-1 replication by attacking the reverse transcriptase enzyme from two different angles. It combines rilpivirine, which binds to a non-active site to disable the enzyme, with emtricitabine and tenofovir alafenamide (TAF), which terminate the growth of the viral DNA chain. The use of TAF allows for high intracellular effectiveness with lower plasma levels, resulting in reduced toxicity to the kidneys and bones.
Form and use:
This medication is a once-daily oral tablet that must be taken with a meal containing at least 533 calories to ensure proper absorption of the rilpivirine component. Failing to eat a full meal or taking the pill only with low-calorie liquids can lead to reduced effectiveness and potential treatment failure. Additionally, patients using acid-reducing medications must follow specific timing precautions to avoid drug interactions.
Generic availability:
As of 2026, there is no generic version of Odefsey available in the United States. While other rilpivirine-based options like Complera and the injectable Cabenuva exist, current medical guidelines often favor integrase-inhibitor-based regimens for patients starting new treatments. Because it remains a brand-only product, it lacks the lower-cost generic alternatives seen with older HIV medications.
Warnings:
Odefsey includes a boxed warning regarding the risk of severe hepatitis B exacerbations if the drug is stopped by co-infected patients, making HBV testing mandatory before treatment begins. It is generally not recommended for patients starting with very high viral loads and carries risks for depressive disorders and liver toxicity. Other precautions include monitoring for QT prolongation, immune reconstitution syndrome, and potential skin or hypersensitivity reactions.
FAQ (Frequently Asked Questions)
How Much Does Odefsey Cost Without Insurance?
Odefsey costs approximately $3,200–$3,700 per 30-day supply. Through AffordMyPrescriptions, qualifying patients receive Odefsey at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Why Does Odefsey Need To Be Taken With A Meal?
Rilpivirine absorption depends on food — specifically a meal of at least 533 calories. Taking Odefsey on an empty stomach or with only a snack can reduce rilpivirine levels by 50% or more, risking virologic failure and resistance. Always take Odefsey with a substantial meal.
How Is Odefsey Different From Complera?
Both contain emtricitabine and rilpivirine. Odefsey uses tenofovir alafenamide (TAF); Complera uses tenofovir disoproxil fumarate (TDF). TAF has less kidney and bone toxicity than TDF. Odefsey is the newer, generally preferred formulation.
Why Aren't NNRTI Regimens Preferred Anymore?
Current HIV guidelines generally prefer integrase-inhibitor-based regimens (Biktarvy, dolutegravir-based) for new starts because integrase inhibitors have a higher barrier to resistance, fewer interactions, and excellent tolerability. Rilpivirine-based regimens like Odefsey are still useful — particularly in patients already suppressed and tolerating them, or those switching for tolerability — but are no longer first-line for treatment-naïve patients with high viral loads.
Can I Get Odefsey Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify, especially if you face specialty-tier copays. State ADAP programs may also coordinate with Medicare for HIV-treatment patients.
What About Drug Interactions With Acid-Reducing Medications?
Rilpivirine absorption depends on stomach acidity. Proton pump inhibitors (omeprazole, esomeprazole, etc.) are contraindicated. H2 blockers (famotidine, ranitidine) must be taken at least 12 hours before or 4 hours after Odefsey. Antacids (Tums, Maalox) must be taken at least 2 hours before or 4 hours after Odefsey.
What If My Application Is Denied?
If denied, we explore alternatives — switching to a different single-tablet regimen with its own PAP, state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Odefsey, our team may be able to help you access assistance programs designed to make brand single-tablet HIV regimens affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.